Education
Olivera graduated from the University of the Philippines in 1960. He received his Doctor of Philosophy from the California Institute of Technology (1966) in Biophysical Chemistry, followed by postdoctoral work at Stanford University from 1966-1968.
Career
These molecules, called conotoxins, led to a breakthrough in the study of ion channels and neuro-muscular synapses. He discovered and first characterized East. coli deoxyribonucleic acid ligase, a key enzyme of genetic engineering and recombinant deoxyribonucleic acid technology. In 1970, he moved to the University of Utah, where he is now a Distinguished Professor of Biology.
His laboratory"s discovery was featured on the cover of the international scientific journal Science in 1990.
He was Harvard 2007 "Scientist of the Year". On July 9, 2007, Uttar Pradesh honored Olivera, for his research on neuropharmacology using the venom of conesnails (carnivorous, predatory marine snails which thrive in tropical and subtropical habitats).
Uttar Pradesh President Doctor Emerlinda Roman said Olivera’s award "brings honor" not only to the Uttar Pradesh community but to the whole country as well.
Membership
He is a Howard Hughes Medical Institute Professor, has been elected into the Institute of Medicine and the American Philosophical Society, and became an Elected Member of the United States. National Academy of Sciences in 2009. His impressive research on both deoxyribonucleic acid biophysics and conotoxins has enabled Doctor Olivera to serve as an editorial board member of various scientific publications. He served as a member of the editorial board of the Journal of Biological Chemistry from 1982 to 1987, the Journal of Toxinology – Toxin Reviews from 1990 to 1993, and Toxicon from 2000 until the present.
In addition, he was a member of the review committee of the journal Cellular and Molecular Basis of Disease from 1982 to 1986.
Doctor Olivera has also served as a committee member of various institutions. He was a member of the Visiting Committee of the Department of Molecular Biology and Biochemistry of Harvard University from 1988 to 1995, the Advisory Committee to the Director of the National Institutes of Health from 1996 to 1999, the Toxicology Advisory Committee of the Burroughs-Wellcome Foundation from 1999 to 2001, and has been a member of the Searle Scholars Advisory Board since 2007.